Global Viral Inactivation Market Size, Status and Forecast 2019-2025

Description

Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
Estimates of their viral inactivation market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.
In 2018, the global Viral Inactivation market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Viral Inactivation status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Viral Inactivation development in United States, Europe and China.

The key players covered in this study
Danaher
Merck
Parker Hannifin
Sartorius
SGS
Charles River Laboratories International
Clean Cells
Rad Source Technologies
Texcell
Viral Inactivated Plasma Systems
Wuxi Pharmatech (Cayman)

Market segment by Type, the product can be split into
Kits and Reagents
Services
Viral Inactivation Systems and Accessories

Market segment by Application, split into
Blood and Blood Products
Cellular and Gene Therapy Products
Stem Cell Products
Tissue and Tissue Products
Vaccines and Therapeutics

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Viral Inactivation status, future forecast, growth opportunity, key market and key players.
To present the Viral Inactivation development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Viral Inactivation are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

TABLE OF CONTENT

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Viral Inactivation Market Size Growth Rate by Type (2014-2025)
1.4.2 Kits and Reagents
1.4.3 Services
1.4.4 Viral Inactivation Systems and Accessories
1.5 Market by Application
1.5.1 Global Viral Inactivation Market Share by Application (2014-2025)
1.5.2 Blood and Blood Products
1.5.3 Cellular and Gene Therapy Products
1.5.4 Stem Cell Products
1.5.5 Tissue and Tissue Products
1.5.6 Vaccines and Therapeutics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Viral Inactivation Market Size
2.2 Viral Inactivation Growth Trends by Regions
2.2.1 Viral Inactivation Market Size by Regions (2014-2025)
2.2.2 Viral Inactivation Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Viral Inactivation Market Size by Manufacturers
3.1.1 Global Viral Inactivation Revenue by Manufacturers (2014-2019)
3.1.2 Global Viral Inactivation Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Viral Inactivation Market Concentration Ratio (CR5 and HHI)
3.2 Viral Inactivation Key Players Head office and Area Served
3.3 Key Players Viral Inactivation Product/Solution/Service
3.4 Date of Enter into Viral Inactivation Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Viral Inactivation Market Size by Type (2014-2019)
4.2 Global Viral Inactivation Market Size by Application (2014-2019)

5 United States
5.1 United States Viral Inactivation Market Size (2014-2019)
5.2 Viral Inactivation Key Players in United States
5.3 United States Viral Inactivation Market Size by Type
5.4 United States Viral Inactivation Market Size by Application

6 Europe
6.1 Europe Viral Inactivation Market Size (2014-2019)
6.2 Viral Inactivation Key Players in Europe
6.3 Europe Viral Inactivation Market Size by Type
6.4 Europe Viral Inactivation Market Size by Application

7 China
7.1 China Viral Inactivation Market Size (2014-2019)
7.2 Viral Inactivation Key Players in China
7.3 China Viral Inactivation Market Size by Type
7.4 China Viral Inactivation Market Size by Application

8 Japan
8.1 Japan Viral Inactivation Market Size (2014-2019)
8.2 Viral Inactivation Key Players in Japan
8.3 Japan Viral Inactivation Market Size by Type
8.4 Japan Viral Inactivation Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Viral Inactivation Market Size (2014-2019)
9.2 Viral Inactivation Key Players in Southeast Asia
9.3 Southeast Asia Viral Inactivation Market Size by Type
9.4 Southeast Asia Viral Inactivation Market Size by Application

10 India
10.1 India Viral Inactivation Market Size (2014-2019)
10.2 Viral Inactivation Key Players in India
10.3 India Viral Inactivation Market Size by Type
10.4 India Viral Inactivation Market Size by Application

11 Central & South America
11.1 Central & South America Viral Inactivation Market Size (2014-2019)
11.2 Viral Inactivation Key Players in Central & South America
11.3 Central & South America Viral Inactivation Market Size by Type
11.4 Central & South America Viral Inactivation Market Size by Application

12 International Players Profiles
12.1 Danaher
12.1.1 Danaher Company Details
12.1.2 Company Description and Business Overview
12.1.3 Viral Inactivation Introduction
12.1.4 Danaher Revenue in Viral Inactivation Business (2014-2019)
12.1.5 Danaher Recent Development
12.2 Merck
12.2.1 Merck Company Details
12.2.2 Company Description and Business Overview
12.2.3 Viral Inactivation Introduction
12.2.4 Merck Revenue in Viral Inactivation Business (2014-2019)
12.2.5 Merck Recent Development
12.3 Parker Hannifin
12.3.1 Parker Hannifin Company Details
12.3.2 Company Description and Business Overview
12.3.3 Viral Inactivation Introduction
12.3.4 Parker Hannifin Revenue in Viral Inactivation Business (2014-2019)
12.3.5 Parker Hannifin Recent Development
12.4 Sartorius
12.4.1 Sartorius Company Details
12.4.2 Company Description and Business Overview
12.4.3 Viral Inactivation Introduction
12.4.4 Sartorius Revenue in Viral Inactivation Business (2014-2019)
12.4.5 Sartorius Recent Development
12.5 SGS
12.5.1 SGS Company Details
12.5.2 Company Description and Business Overview
12.5.3 Viral Inactivation Introduction
12.5.4 SGS Revenue in Viral Inactivation Business (2014-2019)
12.5.5 SGS Recent Development
12.6 Charles River Laboratories International
12.6.1 Charles River Laboratories International Company Details
12.6.2 Company Description and Business Overview
12.6.3 Viral Inactivation Introduction
12.6.4 Charles River Laboratories International Revenue in Viral Inactivation Business (2014-2019)
12.6.5 Charles River Laboratories International Recent Development
12.7 Clean Cells
12.7.1 Clean Cells Company Details
12.7.2 Company Description and Business Overview
12.7.3 Viral Inactivation Introduction
12.7.4 Clean Cells Revenue in Viral Inactivation Business (2014-2019)
12.7.5 Clean Cells Recent Development
12.8 Rad Source Technologies
12.8.1 Rad Source Technologies Company Details
12.8.2 Company Description and Business Overview
12.8.3 Viral Inactivation Introduction
12.8.4 Rad Source Technologies Revenue in Viral Inactivation Business (2014-2019)
12.8.5 Rad Source Technologies Recent Development
12.9 Texcell
12.9.1 Texcell Company Details
12.9.2 Company Description and Business Overview
12.9.3 Viral Inactivation Introduction
12.9.4 Texcell Revenue in Viral Inactivation Business (2014-2019)
12.9.5 Texcell Recent Development
12.10 Viral Inactivated Plasma Systems
12.10.1 Viral Inactivated Plasma Systems Company Details
12.10.2 Company Description and Business Overview
12.10.3 Viral Inactivation Introduction
12.10.4 Viral Inactivated Plasma Systems Revenue in Viral Inactivation Business (2014-2019)
12.10.5 Viral Inactivated Plasma Systems Recent Development
12.11 Wuxi Pharmatech (Cayman)

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

Choose License Type

Checkout Inquiry Sample